Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVH | Class A Common Stock | Award | $0 | +20.4K | +10.61% | $0.00 | 213K | Mar 1, 2023 | Direct | F1, F2, F3 |
transaction | EVH | Class A Common Stock | Tax liability | -$130K | -3.68K | -1.73% | $35.26 | 209K | Mar 1, 2023 | Direct | F3, F4 |
transaction | EVH | Class A Common Stock | Tax liability | -$317K | -9.02K | -4.32% | $35.15 | 200K | Mar 2, 2023 | Direct | F3, F4 |
Id | Content |
---|---|
F1 | Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan. |
F2 | Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026. |
F3 | Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
F4 | This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. |